- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02442024
Metabolic Effects of the Manipulation of Nutrient Sequence in the Main Meals in Type 2 Diabetic Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
An intervention group follows a modified diet over a period of two months in which the ingestion of protein and lipid happens before that of carbohydrates. A control group follows a standardized diet in which the ingestion of carbohydrates happens before that of protein and lipid. Both diets contain a reduced intake of high-glycemic index meals, saturated fatty acids, trans fatty acids and alcohol.
On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet) we measure clinical and metabolic parameters (weight, waist and hip circumferences, glucose, glycated hemoglobin, fructosamine, lipid profile) to compare the effects of the two diets.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Andrea Natali, Professor
- Phone Number: +39050992814
- Email: andrea.natali@med.unipi.it
Study Contact Backup
- Name: Domenico Trico, Dr
- Phone Number: +39050993640
- Email: domenico.trico@for.unipi.it
Study Locations
-
-
PI
-
Pisa, PI, Italy, 56127
- Recruiting
- Azienda Ospedaliero-Universitaria Pisana
-
Contact:
- Andrea Natali, Professor
- Phone Number: 050992814
- Email: andrea.natali@med.unipi.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Well-controlled type 2 diabetes
- HbA1c 48-58 mmol/mol (6.5-7.5%)
- Treatment with metformin or diet only
- BMI: < 35 kg/m^2
Exclusion Criteria:
- Autoimmune diseases, neoplasia, heart, kidney, liver or respiratory failure
- Pregnancy
- Bariatric surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Modified diet
This group will follow a modified diet over a period of two months.
|
Two months of a diet in which the ingestion of protein and lipid precedes that of carbohydrates.
|
Active Comparator: Standard diet
This group will follow a standardized diet over a period of two months.
|
Two months of a diet in which the ingestion of protein and lipid follows that of carbohydrates.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline fructosamine after 1 and 2 months of diet
Time Frame: On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
|
Fructosamine will be measured.
|
On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline fasting plasma glucose after 1 and 2 months of diet
Time Frame: On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
|
Fasting plasma glucose will be measured.
|
On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
|
Change from baseline glycated hemoglobin after 1 and 2 months of diet
Time Frame: On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
|
Glycated hemoglobin will be measured.
|
On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
|
Change from baseline weight after 1 and 2 months of diet adipose tissue location
Time Frame: On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
|
Waist circumference and hip circumference will be measured.
|
On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
|
Change from baseline adipose tissue location after 1 and 2 months of diet
Time Frame: On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
|
Weight, waist circumference and hip circumference will be measured.
|
On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
|
Change from baseline lipid profile after 1 and 2 months of diet
Time Frame: On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
|
Lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides) will be measured.
|
On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
|
Collaborators and Investigators
Investigators
- Study Chair: Andrea Natali, Professor, Azienda Ospedaliero, Universitaria Pisana
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CEPPO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Medical College of WisconsinMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
Joslin Diabetes CenterCambridge Medical Technologies, LLCCompletedType 2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical College of WisconsinMedical University of South Carolina; National Institute of Diabetes and Digestive...Active, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on Modified Diet
-
Seattle Children's HospitalCompleted
-
University College CorkCompleted
-
Vanderbilt UniversityCompletedCircadian Rhythms | MetabolismUnited States
-
Yonsei UniversityCompletedKetogen-based Therapeutic Diet | Pancreaticobiliary CancerKorea, Republic of
-
Hadassah Medical OrganizationCompletedObese Type 2 Diabetic Patients
-
University of Wisconsin, MadisonNational Institutes of Health (NIH); Wisconsin Institute for Clinical and Translational...SuspendedEpilepsy | SeizuresUnited States
-
Johns Hopkins UniversityVascular Birthmarks FoundationCompletedEpilepsy | Sturge Weber SyndromeUnited States
-
Johns Hopkins UniversityCompleted
-
Loma Linda UniversityEnrolling by invitationTraumatic Brain InjuryUnited States
-
Oslo University HospitalCompleted